Correlation Between Bristol Myers and Simulations Plus

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bristol Myers and Simulations Plus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and Simulations Plus into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and Simulations Plus, you can compare the effects of market volatilities on Bristol Myers and Simulations Plus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of Simulations Plus. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and Simulations Plus.

Diversification Opportunities for Bristol Myers and Simulations Plus

-0.48
  Correlation Coefficient

Very good diversification

The 3 months correlation between Bristol and Simulations is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and Simulations Plus in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Simulations Plus and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Simulations Plus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Simulations Plus has no effect on the direction of Bristol Myers i.e., Bristol Myers and Simulations Plus go up and down completely randomly.

Pair Corralation between Bristol Myers and Simulations Plus

Considering the 90-day investment horizon Bristol Myers Squibb is expected to under-perform the Simulations Plus. But the stock apears to be less risky and, when comparing its historical volatility, Bristol Myers Squibb is 1.77 times less risky than Simulations Plus. The stock trades about -0.02 of its potential returns per unit of risk. The Simulations Plus is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  3,935  in Simulations Plus on September 3, 2024 and sell it today you would lose (758.00) from holding Simulations Plus or give up 19.26% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Bristol Myers Squibb  vs.  Simulations Plus

 Performance 
       Timeline  
Bristol Myers Squibb 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady primary indicators, Bristol Myers showed solid returns over the last few months and may actually be approaching a breakup point.
Simulations Plus 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Simulations Plus has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable essential indicators, Simulations Plus is not utilizing all of its potentials. The recent stock price agitation, may contribute to short-term losses for the retail investors.

Bristol Myers and Simulations Plus Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bristol Myers and Simulations Plus

The main advantage of trading using opposite Bristol Myers and Simulations Plus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, Simulations Plus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Simulations Plus will offset losses from the drop in Simulations Plus' long position.
The idea behind Bristol Myers Squibb and Simulations Plus pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Other Complementary Tools

Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio